Furthermore, in a mouse model of PDAC, catecholamines promoted tumor development dependent on the activation of the ADRB2 receptor and NGF secretion, which was reverted by blocking ADRB2 and the NGF receptor [60]. Here, ADRB2 is linked to neoplasm.